Key result
This editorial discusses three potential areas of improvement in the 2012 ACC/AHA stable ischemic heart disease guidelines regarding diagnostic testing, risk-stratification, and treatment approaches.
Answers are grounded in this paper and cite their sources.
This editorial highlights three potential areas for improvement in the 2012 ACC/AHA stable ischemic heart disease guidelines regarding diagnostic testing, risk stratification, and treatment.
The American College of Cardiology/American Heart Association stable ischemic heart disease (SIHD) practice guidelines, published in 2012, represent a tremendous collaborative effort to synthesize the existing literature and evidence base for patients with SIHD. Notably, the guidelines focus not only upon the appropriate identification of patients with SIHD, but also upon the comprehensive treatment of SIHD patients. In doing so, these guidelines have no doubt already helped numerous practicing physicians who have referenced them; however, the goal of guideline documents is not for the included recommendations to be static, but instead to dynamically adapt over time. In this editorial, we discuss three potential areas of improvement in the guidelines, ranging from the use of specific diagnostic testing and risk-stratification modalities to the preferred treatment approach for symptomatic patients with SIHD.
No takes yet. Share an insight, caveat, or question.
Rubin et al. (2014) conducted an editorial in stable ischemic heart disease. This editorial discusses three potential areas of improvement in the 2012 ACC/AHA stable ischemic heart disease guidelines regarding diagnostic testing, risk-stratification, and treatment approaches.
Synapse has enriched 10 related papers. Consider them for comparative context: